Press Releases

The Distribution Agreement Expands KeepZone’s Multi-Layered Homeland Security Portfolio with Advanced Autonomous Aerial Capabilities in One of the World’s Fastest-Growing Security Markets Tel Aviv, Israel, July 29, 2026 (GLOBE NEWSWIRE) -- Nexera Technologies Ltd ("Nexera" or the "Company") (NASDAQ:NEXR, NEXRW)), a data-driven company operating on the Amazon Marketplace expanding into the global homeland security sector through advanced artificial intelligence ("AI")-driven solutions, today announced that its wholly-owned subsidiary, KeepZone AI Inc. ("KeepZone"), has entered into an exclusive distribution agreement (the "Agreement") with Kronomy Ltd. ("Kronomy"), an Israeli provider of

Revenue was $806 million, up 4.3%, and up 5.8% on an organic constant currency (OCC) basis, a non-GAAP measure.Net income was $229 million, down 9.8%.Adjusted EBITDA, a non-GAAP measure, was $464 million, up 4.2%, and up 7.4% on an OCC basis.Diluted GAAP earnings per share (EPS) was $1.75, down 3.3%.Diluted adjusted EPS, a non-GAAP measure, was $1.98, up 5.3%.Net cash provided by operating activities was $366 million, up 49.7% and free cash flow, a non-GAAP measure, was $298 million, up 57.9%.Paid a cash dividend of 50 cents per share on June 30, 2026.Executed a $200 million Accelerated Share Repurchase program. JERSEY CITY, N.J., July 29, 2026 (GLOBE NEWSWIRE) -- Verisk (NASDAQ:VRSK), a

PORTLAND, Ore., July 29, 2026 /PRNewswire/ -- Trace Biosciences, Inc., a clinical-stage biotechnology company developing nerve-targeted imaging agents, today announced it has received a strategic investment from Axogen, Inc. (NASDAQ:AXGN), the global leader in surgical solutions for restoration of peripheral nerve function, as its technology continues to advance through clinical development. The investment is part of Trace's Series A financing round with additional investors expected to join. Nerve Trace is a near-infrared fluorescence imaging technology designed to provide direct, real-time visualization of nerves during surge

2026 CAPEX raised to US$2bn to support phased expansion plan Q2 2026 operating income increases 32.6% QoQ while Q3 utilization to exceed 90% Second Quarter 2026 Overview1: Revenue: NT$68.73 billion (US$2.18 billion) Gross margin: 32.5%; Operating margin: 21.8% Revenue from 22/28nm: 37% Capacity utilization rate: 85% Net income attributable to shareholders of the parent: NT$42.26 billion (US$1.34 billion) Earnings per share: NT$3.39; earnings per ADS: US$0.537   United Microelectronics Corporation (NYSE:UMC, TWSE: 2303)) ("UMC" or "The Company"), a leading global semiconductor foundry, today announced its consolidated operating results for the second quarter of 202

AUSTIN, Texas, July 29, 2026 /PRNewswire/ -- Flex (NASDAQ:FLEX) today announced key leadership roles for both Flex and "SpinCo," the planned independent, publicly traded company comprising its Cloud and Power Infrastructure segment following the expected spin-off in the first calendar quarter of 2027 (Spin-Off).  These appointments further strengthen the leadership teams expected to lead both companies following the Spin-Off, alongside previously announced Chief Executive Officers Revathi Advaithi and Michael Hartung at SpinCo and Flex, respectively.SpinCo Leadership Bill Watkins, Non-Executive Chairman of the Board of DirectorsRevathi Advaithi, Chief Executive OfficerKevin Krumm, Chief Fina

Reported Q1 net sales of $7.9 billion, up 21% versus the prior year.Delivered Q1 GAAP operating margin of 4.9%, and adjusted operating margin of 6.7%.Reported Q1 GAAP EPS of $0.76, and record adjusted EPS of $1.00.Announced Investor Day date of November 10th, 2026.AUSTIN, Texas, July 29, 2026 /PRNewswire/ -- Flex (NASDAQ:FLEX) today announced results for its first quarter ended June 26, 2026."This quarter reflects the continued execution of the strategy we've advanced over the last several years. From joining the S&P 500 to expanding our role in AI infrastructure, we've strengthened our position in attractive growth markets. Looking ahead, we're confident both Flex and SpinCo have the leader

Commercial Channel Revenue Increased 17% to a Record $13.9 Million Delivered $3.3 Million of Net Income, 65% Gross Margin, and $7.1 Million of Adjusted EBITDA, Highest Since 2020 Raising Full-Year 2026 Financial Guidance and Revising 2027 Revenue Forecast BEDFORD, Mass., July 29, 2026 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ:ANIK), a global leader in the osteoarthritis ("OA") pain management and regenerative solutions spaces focused on early-intervention orthopedics, today announced financial results for the second quarter of 2026. Total revenue for the second quarter was $32.6 million, compared to $28.2 million in the prior-year period. Performance was driven by record Com

ALACHUA, Fla. and TAMPA, Fla., July 29, 2026 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ:AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral nerve function, today reported financial results and business highlights for the second quarter ended June 30, 2026. Second Quarter Financial Results Revenue was $69.7 million, an increase of 23.1% compared with $56.7 million in the second quarter of 2025.Gross margin was 72.7% compared to 74.2% in the second quarter of 2025. Gross margin performance was driven by changes in product mix caused primarily by accelerating year over year Breast growth greater than 50%.Net loss was $1.5

~ U.S. and U.K. regulatory submissions for AMT-130 for Huntington’s disease on track as planned for the third quarter of 2026 ~ ~ Topline four-year data from the Phase I/II study of AMT-130 expected in September 2026 ~ ~ Reported data from the first cohort in the Phase I/IIa trial of AMT-260 for refractory mesial temporal lobe epilepsy showed early biological signals of therapeutic activity and a favorable safety profile ~ ~ Strengthened financial position with $259 million follow-on offering, extending cash runway into 2030 and funding the anticipated commercial launch of AMT-130 and continued pipeline investment ~ ~ uniQure to host earnings call at 8:30 a.m. ET ~ LEXINGTON, Mass. and

Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) announced today that Frank Bennett, Ph.D., executive vice president and chief scientific officer, will retire effective February 2027."As a founding scientist, Frank has been instrumental in shaping Ionis and advancing the entire field of RNA-targeted medicines," said Brett P. Monia, Ph.D., chief executive officer, Ionis. "Frank’s profound contributions include pioneering the use of antisense medicines in neurological disease. He led the discovery and development of the first approved medicines for spinal muscular atrophy and a genetic form of amyotrophic lateral sclerosis, which have transformed the lives of thousands of people. We are deeply gratef

ROSH-HA`AYIN, Israel, July 29, 2026 (GLOBE NEWSWIRE) -- Kornit Digital Ltd. ("Kornit" or the "Company") (NASDAQ:KRNT), a global leader in sustainable, on-demand, digital fashion and textile production, announced today that it will release its financial results for the second quarter ended June 30, 2026, on Wednesday, August 12, prior to the market open. The Company will host an earnings conference call and webcast reviewing these results and its operations on Wednesday, August 12, 2026, at 8:30 am ET. The live webcast can be accessed here. The webcast will also be available through the investors section of Kornit’s website, at ir.kornit.com. The dial-in information for the live call is:

Toronto, Ontario--(Newsfile Corp. - July 29, 2026) - White Gold Corp. (TSXV:WGO) (OTCQX:WHGOF) (FSE: 29W) ("White Gold" or the "Company") is pleased to provide an update on its fully funded 2026 exploration program across its district-scale land package in the emerging White Gold District in Yukon, Canada. The primary objective of the 2026 program is to expand the Company's known gold resources by targeting high probability near deposit mineralization on its Golden Saddle, Arc, Ryan's Surprise, and VG deposits, and to make new discoveries in close proximity to these deposits. With a significantly larger 2026 exploration program, resource-growth drilling will build on the success of the 2025

RMAT designation is intended to help expedite development of new regenerative medicines that have potential to treat serious medical conditions with significant unmet needThe designation could accelerate OCU410’s regulatory path while further differentiating its one-time treatment for life approach from current therapies requiring chronic administration MALVERN, Pa, July 29, 2026 (GLOBE NEWSWIRE) -- Ocugen, Inc. ("Ocugen" or the "Company") (NASDAQ:OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that the U.S. Food and Drug Administration (FDA) has granted RMAT designation to Ocugen’s investigational product OCU410 for the treatment of geog

Company Expects to Finish Fiscal Year 2026 in the Upper Half of Financial Guidance Ranges CHARLESTON, S.C., July 29, 2026 /PRNewswire/ -- Blackbaud (NASDAQ:BLKB), the world's leading provider of AI-powered solutions for social impact, today announced financial results for its second quarter ended June 30, 2026."Our second quarter and first-half results came in as expected, and combined with our confidence in the second half, position us to finish in the upper half of our FY26 guidance ranges for revenue, adjusted EBITDA, non-GAAP EPS, and free cash flow, with EPS and free cash flow at the high end," said Mike Gianoni, president, CEO and vice chairman of the board of directors, Blackbaud. "We

Executive Chairman Jon Moeller to Retire The Procter & Gamble Company (NYSE:PG) today announced that Shailesh Jejurikar has been appointed Chairman of the Board, effective August 1, 2026. Jejurikar assumes the position in addition to his role as President and Chief Executive Officer. Jon Moeller, Executive Chairman, will retire from the Board effective July 31, 2026, and from P&G effective August 14, 2026. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260729911506/en/Shailesh G. Jejurika, President and Chief Executive Officer "I want to thank Jon for his many years of tireless and steady leadership at P&G, having served in ke

NORTHBROOK, Ill., July 29, 2026 /PRNewswire/ -- Stepan Company (NYSE:SCL) today reported: Second Quarter 2026 HighlightsReported net income was $22.9 million, up 102% versus the prior year. Adjusted net income(1) was $27.1 million, up 126% versus the prior year.EBITDA(2) was $69.1 million and Adjusted EBITDA(2) was $74.4 million, up 37% and 45% respectively, year-over-year.Global sales volume was up 3% year-over-year. Organic sales volume was up 6% year-over-year.      Cash from Operations was $8.4 million during the quarter. Free cash flow(3) for the quarter was a negative $15.0 million, driven by higher working capital requir

Revenue $14.1 billion, up 8.1% versus prior yearDiluted EPS $4.24, up 13.4% versus prior year$1.9 billion cash from operating activities, 162% of net earnings1.4-to-1 book-to-bill, with strong order activity in all segmentsRESTON, Va., July 29, 2026 /PRNewswire/ -- General Dynamics (NYSE:GD) today reported second-quarter 2026 operating earnings of $1.5 billion, and $4.24 per diluted share (EPS), on revenue of $14.1 billion. Compared with the year-ago quarter, revenue increased 8.1%, operating earnings increased 11.9%, and diluted EPS increased 13.4%. Operating margin of 10.4% was a 40-basis-point expansion from the year-ago quarter."Our businesses delivered solid results in the quarter, with

ROSELAND, N.J., July 29, 2026 /PRNewswire/ -- ADP (NASDAQ:ADP), a global leader in HR and payroll solutions, today announced its fourth quarter and fiscal 2026 financial results along with its fiscal 2027 outlook through an earnings release available on the company's website at investors.adp.com/events-and-presentations. This earnings release will also be furnished to the Securities and Exchange Commission (SEC) on a Current Report on Form 8-K and available at sec.gov.As previously announced, ADP will host a conference call for financial analysts today, Wednesday, July 29, 2026 at 8:30 a.m. ET. The conference call will be webcast live on ADP's website at investors.adp.com and will be availab

FDA aligned on new-onset severe respiratory failure as the Phase 2b primary endpoint, with multi-organ failure and time to medically indicated discharge as key secondary endpointsFDA aligned on a strategy to evaluate elevated lactate dehydrogenase (LDH) as a potential enrichment marker for identifying patients at increased risk of new-onset severe respiratory failureLA JOLLA, Calif., July 29, 2026 /PRNewswire/ -- CalciMedica, Inc. ("CalciMedica" or the "Company") (NASDAQ:CALC), a clinical-stage biopharmaceutical company developing calcium release-activated calcium (CRAC) channel inhibition therapies for serious inflammatory, immunologic, and cardiopulmonary diseases, today announced that, fo

Revenue of $220 million, up 22% year-over-year, and Adjusted EBITDA of $28 million, up 27% year-over-year, with record Adjusted EBITDA margin of 18%Raising full-year 2026 outlook on sustained demand strength and accelerating business model fundamentalsVoice AI adoption driving enterprise modernization and $1m+ strategic customer winsRALEIGH, N.C., July 29, 2026 /PRNewswire/ -- Bandwidth Inc. (NASDAQ:BAND), a leading global enterprise cloud communications company, today announced financial results for the second quarter ended June 30, 2026. "AI is reshaping how enterprises evaluate communications infrastructure, increasing deman